NORTH CHICAGO, Ill., April 6, 2016 /PRNewswire/ -- AbbVie today announced that the 2016 AbbVie CF Scholarship, which honors and supports young adults with cystic fibrosis (CF) as they pursue higher education, is now accepting applications. Undergraduate and graduate students can apply for the scholarship from now until May 27, 2016 at 10:00 a.m. U.S. central time by visiting www.AbbVieCFScholarship.com.

NORTH CHICAGO, Ill., April 5, 2016 /PRNewswire/ -- AbbVie today announced a partnership with celebrity dietitian Joy Bauer to raise awareness about the importance of a healthy diet and lifestyle for people with a little-known gastrointestinal (GI) condition called exocrine pancreatic insufficiency (EPI). The renowned dietitian and television personality drew upon the expertise from her 25-year career to develop a guide containing nutrition tips and healthy recipes for this community of patients. The nutrition guide, along with additional information on EPI can be found at www.identifyepi.com/joybauer.

NORTH CHICAGO, Ill., April 4, 2016 /PRNewswire/ -- AbbVie (NYSE: ABBV), a global biopharmaceutical company, announced today that the European Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has granted a positive opinion for HUMIRA® (adalimumab) for the treatment of moderately to severely active Crohn's disease in pediatric patients (from six years of age) who have had an inadequate response to conventional therapy including primary nutrition therapy and a corticosteroid and/or an immunomodulator, or who are intolerant to or have contraindications for such therapies.